Connect with us

Hi, what are you looking for?

Monday, Feb 26, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

Charlotte’s Web expands CBD market share lead with Abacus Health acquisition

The companies said they will own 35 per cent of the lucrative U.S. CBD market post-merger

Charlotte's Web expands CBD market share lead with Abacus Health acquisition
Charlotte's Web expands CBD market share lead with Abacus Health acquisition

CBD heavyweight Charlotte’s Web (TSX: CWEB) said it has doubled its U.S. market share lead by scooping up CBD topical specialist Abacus Health Products, Inc. (CSE:ABCS).

The Colorado CBD company announced Monday it’s set to acquire Rhode Island-based Abacus Health in an all-stock deal worth $99 million.

Abacus is backed by former NFL star linebacker Rob Gronkowski and the company sells 50 different hemp-derived CBD topical products — many under its CBDMedic brand — in 12,000 different stores across the U.S.

Combined, Charlotte’s Web said the merger deal will create the world’s largest hemp CBD company that owns 35 per cent of the U.S. cannabidiol market.

Charlotte’s Web sells CBD-infused pet products, edibles and topicals in 11,000 U.S. retailers. Accounting for overlap, the two companies will combine to have products inside 15,000 locations, while having access to Abacus Health’s large network of health care practitioners.

“Because most of Abacus’s products are positioned in adjacent categories, our combined distribution reach has limited shelf overlap,” CWEB CEO Deanie Elsner said in a statement.

“Together we are the most developed CBD company across every channel and segment and positioned to accelerate our growth and extend our market share.”

Elsner added the post-merger company will consolidate production and sales infrastructure, increasing economies of scale, lowering costs and reaching new markets in the process.

On pro forma basis, the company’s cash position is an estimated US$90.4 million, as of Dec. 31, to fund further expansion.

The deal has been approved by both companies’ boards of directors, but it still requires a go-ahead from Abacus shareholders who are set to vote in the near term. The companies expect the deal to close in the second quarter of 2020.

Abacus shareholders will receive 0.85 of a common share of Charlotte’s Web for each share held. The exchange ratio implies a price per Abacus Share of $4.39, based on the 10-day volume weighted average price of $5.17, representing a premium of 38 per cent.

Charlotte’s Web will host a conference call tomorrow at 8:30 a.m. Eastern Time to discuss more details of the deal, after the company reports its financials for the fourth quarter and year ended Dec. 31, 2019.

Read more: Charlotte’s Web increases yield, CBD potency in 2019 hemp harvest

Read more: Rob Gronkowski teams up with CBD company

Top image via Charlotte’s Web


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Its subsidiary Valiant will be distribute merchandise for the Manitoba Liquor and Lotteries Corporation


Elevating animal healthcare with the cannabis conundrum in veterinary medicine


Ovation will provide Planet 13 with manufacturing, sales and marketing rights for its topical/transdermal products in Nevada


The CBD oil is produced at Aurora's production facility in Uruguay